AIBullishcrypto.news · 8h ago6/10
🧠
Senhwa Biosciences inks up to $16M funding deal with GEM to boost AI drug discovery
Taiwanese biopharmaceutical company Senhwa Biosciences has secured up to $16 million in funding from GEM through a memorandum of understanding to accelerate AI-driven drug discovery. This partnership represents growing institutional investment in combining artificial intelligence with pharmaceutical development to expedite clinical-stage research.
